Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Characterization of a new cytogenetic subtype of ductal breast carcinomas

Oncogene volume 23, pages 5986–5993 (2004)Cite this article

Abstract

About 50% of ductal breast carcinomas do not yield analysable karyotypes after short-term culturing. Comparison of the cytogenetic subset to the whole data set of tumors revealed that slightly hyperdiploid tumors, that is, with DNA index between 1.05 and 1.3, were under-represented in tumors for which cytogenetic analysis was successful. The purpose of this study was to determine whether the pattern of chromosome imbalances in this subset differs from that generally reported. Comparative genomic hybridization (CGH) was used on 43 primary ductal breast carcinomas selected for slight hyperdiploidy. Microsatellite instability (MSI), TP53 mutation and expression were also investigated. All tumors were MSI negative. In all, 18 tumors (42%) presented mostly unbalanced chromosome rearrangements and DNA amplifications, with only few or no whole chromosome gains (WCG). This pattern of chromosome imbalances corresponds to that described in most breast tumors by previous cytogenetic and CGH analyses. It was associated with TP53 mutation in 17% of tumors. Another subset of 17 tumors (39%) displayed different and new features, characterized by recurrent gains of whole chromosomes 5, 7 and 8 with few chromosome rearrangements, rare DNA amplifications and no TP53 mutation. Eight tumors with as many rearrangements as WCG were left unclassified. We propose that, beside a major pathway characterized by multiple chromosome rearrangements, there is a minor pathway mainly characterized by WCG.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

Accession codes

Accessions

GenBank/EMBL/DDBJ

References

  • Aaltonen LA, Peltomaki P, Leach FS, Sistonen P, Pylkkanen L, Mecklin JP, Jarvinen H, Powell SM, Jen J, Hamilton SR, Petersen GM, Kinzler KW, Vogelstein B and de la Chapelle A . (1993). Science, 260, 812–816.

  • Anbazhagan R, Fujii H and Gabrielson E . (1999). Clin. Cancer Res., 5, 839–844.

  • Bernardino J, Gerbault-Seureau M, Sastre X and Dutrillaux B . (1997). Genes Chromosomes Cancer, 19, 195–199.

  • Bieche I and Lidereau R . (1995). Genes Chromosomes Cancer, 14, 227–251.

  • Buerger H, Mommers EC, Littmann R, Simon R, Diallo R, Poremba C, Dockhorn-Dworniczak B, van Diest PJ and Boecker W . (2001). J. Pathol., 194, 165–170.

  • Courjal F and Theillet C . (1997). Cancer Res., 57, 4368–4377.

  • Delattre O, Olschwang S, Law DJ, Melot T, Remvikos Y, Salmon RJ, Sastre X, Validire P, Feinberg AP and Thomas G . (1989). Lancet, 2, 353–356.

  • Dellas A, Torhorst J, Schultheiss E, Mihatsch MJ and Moch H . (2002). Clin. Cancer Res., 8, 1210–1216.

  • Devilee P and Cornelisse CJ . (1994). Biochim. Biophys. Acta, 1198, 113–130.

  • Dutrillaux B . (2000). Chromosome and Gene Alterations in Human Cancers in Relation to Aging, Olmo E and Redi CA (eds) Birkhäuser Verlag: Switzerland.

    Book  Google Scholar 

  • Dutrillaux B, Gerbault-Seureau M, Remvikos Y, Zafrani B and Prieur M . (1991). Breast Cancer Res. Treat., 19, 245–255.

  • Dutrillaux B, Gerbault-Seureau M and Zafrani B . (1990). Cancer Genet. Cytogenet., 49, 203–217.

  • Fearon ER and Vogelstein B . (1990). Cell, 61, 759–767.

  • Georgiades IB, Curtis LJ, Morris RM, Bird CC and Wyllie AH . (1999). Oncogene, 18, 7933–7940.

  • Haydon AM and Jass JR . (2002). Lancet Oncol., 3, 83–88.

  • Hoang JM, Cottu PH, Thuille B, Salmon RJ, Thomas G and Hamelin R . (1997). Cancer Res., 57, 300–303.

  • Hoglund M, Gisselsson D, Hansen GB, Sall T and Mitelman F . (2002). Cancer Res., 62, 2675–2680.

  • Ionov Y, Peinado MA, Malkhosyan S, Shibata D and Perucho M . (1993). Nature, 363, 558–561.

  • Isola JJ, Kallioniemi OP, Chu LW, Fuqua SA, Hilsenbeck SG, Osborne CK and Waldman FM . (1995). Am. J. Pathol., 147, 905–911.

  • Jallepalli PV and Lengauer C . (2001). Nat. Rev. Cancer, 1, 109–117.

  • Kallioniemi OP, Kallioniemi A, Piper J, Isola J, Waldman FM, Gray JW and Pinkel D . (1994). Genes Chromosomes Cancer, 10, 231–243.

  • Kuukasjarvi T, Karhu R, Tanner M, Kahkonen M, Schaffer A, Nupponen N, Pennanen S, Kallioniemi A, Kallioniemi OP and Isola J . (1997). Cancer Res., 57, 1597–1604.

  • Lesec G, Richard-Coulet E, Collet JF, De Maublanc MA, Merle S, Salmon R and Remvikos Y . (1997). Int. J. Oncol., 10, 747–752.

  • Lothe RA, Peltomaki P, Meling GI, Aaltonen LA, Nystrom-Lahti M, Pylkkanen L, Heimdal K, Andersen TI, Moller P, Rognum TO, Fossa SD, Haldorsen T, Langmark F, Brogger A, de la Chapelle A and Borresen AL . (1993). Cancer Res., 53, 5849–5852.

  • Loveday RL, Greenman J, Simcox DL, Speirs V, Drew PJ, Monson JR and Kerin MJ . (2000). Int. J. Cancer, 86, 494–500.

  • Muleris M and Dutrillaux B . (1996). Cancer Genet. Cytogenet., 92, 11–13.

  • Muleris M, Salmon RJ and Dutrillaux B . (1988). Cancer Genet. Cytogenet., 32, 43–50.

  • Muleris M, Salmon RJ and Dutrillaux B . (1990). Cancer Genet. Cytogenet., 46, 143–156.

  • Murata H, Khattar NH, Kang Y, Gu L and Li GM . (2002). Oncogene, 21, 5696–5703.

  • Nishizaki T, DeVries S, Chew K, Goodson III WH, Ljung BM, Thor A and Waldman FM . (1997). Genes Chromosomes Cancer, 19, 267–272.

  • Olivier M, Eeles R, Hollstein M, Khan MA, Harris CC and Hainaut P . (2002). Hum. Mutat., 19, 607–614.

  • Pandis N, Jin Y, Gorunova L, Petersson C, Bardi G, Idvall I, Johansson B, Ingvar C, Mandahl N, Mitelman F and Heim S . (1995). Genes Chromosomes Cancer, 12, 173–185.

  • Paulson TG, Wright FA, Parker BA, Russack V and Wahl GM . (1996). Cancer Res., 56, 4021–4026.

  • Remvikos Y, Muleris M, Salmon RJ and Dutrillaux B . (1997). Cancer Genet. Cytogenet., 93, 63–73.

  • Remvikos Y, Vielh P, Padoy E, Benyahia B, Voillemot N and Magdelenat H . (1991). Br. J. Cancer, 64, 501–507.

  • Remvikos Y, Vogt N, Muleris M, Salmon RJ, Malfoy B and Dutrillaux B . (1995). Genes Chromosomes Cancer, 12, 272–276.

  • Ried T, Just KE, Holtgreve-Grez H, du Manoir S, Speicher MR, Schrock E, Latham C, Blegen H, Zetterberg A, Cremer T and Auer G . (1995). Cancer Res., 55, 5415–5423.

  • Roylance R, Gorman P, Harris W, Liebmann R, Barnes D, Hanby A and Sheer D . (1999). Cancer Res., 59, 1433–1436.

  • Sandberg AA and Bridge JA . (2000). Cancer Genet. Cytogenet., 123, 1–26.

  • Shackney SE and Shankey TV . (1997). Cytometry, 29, 1–27.

  • Shaw JA, Walsh T, Chappell SA, Carey N, Johnson K and Walker RA . (1996). Br. J. Cancer, 73, 1393–1397.

  • Soulie P, Poupon MF, Remvikos Y, Dutrillaux B and Muleris M . (1999). Oncogene, 18, 775–781.

  • Soussi T, Dehouche K and Beroud C . (2000). Hum. Mutat., 15, 105–113.

  • Tanner MM, Karhu RA, Nupponen NN, Borg A, Baldetorp B, Pejovic T, Ferno M, Killander D and Isola JJ . (1998). Am. J. Pathol., 153, 191–199.

  • Teixeira MR, Pandis N and Heim S . (2002). Genes Chromosomes Cancer, 33, 1–16.

  • Thibodeau SN, Bren G and Schaid D . (1993). Science, 260, 816–819.

  • Tirkkonen M, Tanner M, Karhu R, Kallioniemi A, Isola J and Kallioniemi OP . (1998). Genes Chromosomes Cancer, 21, 177–184.

  • Walsh T, Chappell SA, Shaw JA and Walker RA . (1998). J. Pathol., 185, 18–24.

  • Zhou XP, Hoang JM, Li YJ, Seruca R, Carneiro F, Sobrinho-Simoes M, Lothe RA, Gleeson CM, Russell SE, Muzeau F, Flejou JF, Hoang-Xuan K, Lidereau R, Thomas G and Hamelin R . (1998). Genes Chromosomes Cancer, 21, 101–107.

Download references

Acknowledgements

We thank Michelle Debatisse for critical reading of the manuscript. This work was supported by PIC genetique et biologie des cancers du sein.

Author information

Authors and Affiliations

  1. FRE 2584 CNRS, Institut Curie, 26 rue d'Ulm, Paris, 75248, France

    Romain Molist, Yorghos Remvikos, Bernard Dutrillaux & Martine Muleris

Authors
  1. Romain Molist
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yorghos Remvikos
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bernard Dutrillaux
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Martine Muleris
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Martine Muleris.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Molist, R., Remvikos, Y., Dutrillaux, B. et al. Characterization of a new cytogenetic subtype of ductal breast carcinomas. Oncogene 23, 5986–5993 (2004). https://doi.org/10.1038/sj.onc.1207799

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1207799

Keywords

This article is cited by

Search

Advanced search

Quick links